Traditional Chinese medicine composition for treating radiation-induced intestinal injury and application thereof

By using extracts of traditional Chinese medicine compositions of Baitou, Qinpi, Huangbai and Coptis chinensis, the shortcomings of radiation enteropathy in the prior art are solved, and the intestinal inflammation is reduced and antioxidant capacity is improved, and intestinal cell proliferation and mucus are promoted. Layer formation improves the effect of intestinal barrier function.

CN118903284APending Publication Date: 2024-11-08FOURTH MILITARY MEDICAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410900991.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-05
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The prior art is difficult to effectively treat radiation enteropathy, especially due to its long course and complex pathogenesis, the single ingredients of Western medicine cannot be treated with targeted treatment.

Method used

Using a traditional Chinese medicine composition, including Baitou, Qinpi, Huangbo and Coptis chinensis, the extract is prepared by soaking, decocting and drying, which is used to reduce intestinal pathological damage, improve antioxidant ability, reduce the level of inflammatory factors, and promote intestinal tract. Cell proliferation and mucin secretion protect the intestinal mucosal barrier.

Benefits of technology

Significantly alleviates intestinal inflammation, reduces intestinal tissue damage, improves intestinal antioxidant capacity, promotes intestinal cell proliferation and mucus formation, improves intestinal barrier function, and effectively alleviates and treats radiation enteropathy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004930464140000051
    Figure BDA0004930464140000051
Patent Text Reader

Abstract

The invention discloses a traditional Chinese medicine composition for treating radiation-induced intestinal injury and application of the traditional Chinese medicine composition, and belongs to the technical field of medicines. The traditional Chinese medicine composition comprises the following components in parts by weight: 5-30 parts of Chinese pulsatilla root, 4-24 parts of cortex fraxini, 4-24 parts of cortex phellodendri and 3-18 parts of rhizoma coptidis. The compound can significantly relieve intestinal mucosa atrophy and intestinal villus shedding, reduce the Chiu's score of intestinal tissue damage, and increase the length of intestinal villus and the number of crypts; the composition can inhibit the level of proinflammatory factors, promote secretion of anti-inflammatory factors, relieve intestinal inflammation, improve the SOD activity, reduce the MDA content and improve the antioxidant capacity of intestinal tracts; the apoptosis of intestinal cells is reduced, the proliferation of the intestinal cells is promoted, and the intestinal barrier function and cell replacement balance of the mouse are guaranteed; the traditional Chinese medicine composition can effectively relieve intestinal mucosa goblet cell damage caused by radiation, promote formation of an intestinal mucous layer and reduce intestinal mucosa permeability, so that the intestinal barrier function of mice is improved, and the effect of effectively treating the radiation bowel disease is achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of medical technology, and in particular to a Chinese medicine composition for treating radiation-induced intestinal injury and application thereof. Background Art

[0002] At present, ionizing radiation is widely used in many fields such as medicine, military, energy and agriculture. While it benefits human life, it is also accompanied by potential safety hazards. Radiation therapy has the risk of radiation enteropathy for patients, which is clinically manifested by abdominal pain, diarrhea, blood in the stool and tenesmus, and even endangers the patient's life and seriously reduces the patient's quality of life.

[0003] Radiation enteropathy has the characteristics of long course and complex pathogenesis, and there is no effective treatment at present. Western medicine has a single ingredient and a single mechanism, and it is difficult to effectively treat radiation enteropathy with complex pathogenesis. However, traditional Chinese medicine adopts a holistic concept and dialectical treatment method, which is likely to have a better clinical treatment effect on radiation enteropathy. A traditional Chinese medicine composition that can effectively treat radiation intestinal damage is urgently needed. Summary of the invention

[0004] In order to solve the above technical problems, the purpose of the present invention is to provide a Chinese medicine composition for treating radiation-induced intestinal injury and its application, so as to solve the problem of the lack of effective drugs for treating radiation enteropathy with a long course and complex pathogenesis.

[0005] The technical solution of the present invention to solve the above technical problems is as follows:

[0006] A traditional Chinese medicine composition for treating radiation-induced intestinal injury comprises the following components in parts by weight: 5-30 parts of Pulsatilla striata, 4-24 parts of Fraxinus frass, 4-24 parts of Phellodendron chinense and 3-18 parts of Coptis chinensis.

[0007] The beneficial effects of the present invention are as follows: the present invention provides a traditional Chinese medicine composition for treating radiation-induced intestinal injury, which can effectively alleviate and treat radiation enteropathy by reducing intestinal pathological damage, reducing intestinal bleeding, improving intestinal antioxidant capacity and reducing inflammatory factor levels, reducing intestinal cell apoptosis, promoting intestinal cell proliferation, promoting intestinal mucin secretion, and protecting the intestinal mucosal barrier.

[0008] Further, the following components are included in parts by weight: 16.5 parts of Pulsatilla scabra, 13.2 parts of Fraxinus frassifolia, 13.2 parts of Phellodendron chinense and 6.6 parts of Coptis chinensis.

[0009] A method for preparing a Chinese medicine composition extract for treating radiation-induced intestinal damage comprises the following steps:

[0010] (1) Weigh the Chinese medicine composition according to claim 1 or 2 and soak it in water;

[0011] (2) decocting the soaked medicinal materials and the soaking liquid in step (1) to obtain a compound medicinal liquid;

[0012] (3) The compound medicinal solution obtained in step (2) is concentrated and dried to obtain the product.

[0013] The beneficial effects of the present invention are as follows: the present invention provides a method for preparing a Chinese medicine composition extract for treating radiation-induced intestinal injury, the preparation method is simple, and the prepared Chinese medicine composition extract can significantly reduce intestinal mucosal atrophy and shedding of intestinal villi, reduce the Chiu's score of intestinal tissue damage, increase the length of intestinal villi and the number of crypts; inhibit the level of pro-inflammatory factors, promote the secretion of anti-inflammatory factors, reduce intestinal inflammation, increase SOD activity and reduce MDA content, and improve the antioxidant capacity of the intestine; reduce intestinal cell apoptosis and promote intestinal cell proliferation, and ensure the balance between mouse intestinal barrier function and cell replacement; can effectively reduce radiation-induced intestinal mucosal goblet cell damage, promote the formation of intestinal mucus layer, reduce intestinal mucosal permeability, and thus improve mouse intestinal barrier function.

[0014] Furthermore, in step (1), the mass ratio of the Chinese medicine composition to water is 1:5-15, and the soaking time is 0.5-2h.

[0015] Preferably, in step (1), the mass ratio of the Chinese medicine composition to water is 1:10, and the soaking time is 1 hour.

[0016] Furthermore, the decoction method in step (2) is: first decoct the medicinal materials and the infusion for 0.5 to 2 hours, filter the medicinal solution, then add water 3 to 8 times the weight of the medicinal materials and decoct again for 0.5 to 2 hours, filter and combine the medicinal solutions obtained from the two decoctions.

[0017] Preferably, the decoction method in step (2) is: first decoct the medicinal materials and the infusion for 1 hour, filter the medicinal solution, then add water 5 times the weight of the medicinal materials and decoct again for 1 hour, filter and combine the medicinal solutions obtained from the two decoctions.

[0018] Furthermore, the drying conditions in step (3) are: first treating the concentrated product at -90 to -70°C overnight, and then freeze-drying for 24 to 72 hours.

[0019] Preferably, the drying conditions in step (3) are: first treating the concentrated product at -80°C overnight, and then freeze-drying for 48 hours.

[0020] A Chinese medicine composition extract for treating radiation-induced intestinal damage is prepared by the above preparation method.

[0021] Application of the above Chinese medicine composition or Chinese medicine composition extract in preparing medicine for treating radiation enteropathy.

[0022] Further, radiation enteropathy includes acute radiation enteropathy, chronic radiation enteropathy, ulcerative colitis and intestinal obstruction.

[0023] A medicine for treating radiation enteropathy, the active ingredients of which include the above-mentioned Chinese medicine composition or Chinese medicine composition extract.

[0024] The present invention has the following beneficial effects:

[0025] The present invention provides a Chinese medicine composition for treating radiation-induced intestinal injury based on clinical symptoms such as abdominal pain, diarrhea, blood in stool and tenesmus. Experiments show that the Chinese medicine composition has no toxic side effects and has good safety. The four medicinal materials are all common medicinal materials, with easy cost control and good efficacy. They can relieve and treat radiation enteropathy by playing the roles of clearing away heat and detoxifying, cooling blood, drying dampness and stopping dysentery, anti-inflammatory, anti-oxidation, protecting intestinal mucosa, anti-apoptosis and promoting proliferation. DETAILED DESCRIPTION

[0026] The principles and features of the present invention are described below in conjunction with the examples, which are only used to explain the present invention and are not intended to limit the scope of the present invention. If no specific conditions are specified in the examples, the conditions are carried out according to conventional conditions or the conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments is not specified, they are all conventional products that can be purchased commercially.

[0027] Embodiment 1:

[0028] A method for preparing a Chinese medicine composition extract for treating radiation-induced intestinal damage comprises the following steps:

[0029] (1) Cut the dried Pulsatilla striata, Phellodendron amurense, Coptis chinensis and Fraxinus chinensis into small pieces, weigh 165 g of Pulsatilla striata, 132 g of Phellodendron amurense, 66 g of Coptis chinensis and 132 g of Fraxinus chinensis, and soak them in 5 L of water for 1 h;

[0030] (2) pouring the soaked medicinal materials and the extract from step (1) into a multifunctional dynamic extraction tank and boiling for 1 hour, filtering the medicinal solution, then adding 2.5L of water and continuing to boil for 1 hour, filtering the medicinal solution and combining the two medicinal solutions to obtain a compound medicinal solution;

[0031] (3) The compound medicinal liquid obtained in step (2) was concentrated using a multifunctional dynamic extraction concentrator to obtain an extract, which was then poured into an evaporating dish and placed in a -80°C refrigerator overnight. The next day, the evaporating dish was placed in a freeze dryer for freeze drying for 48 hours to obtain a Chinese medicine composition extract with a crude drug extraction rate of 24.6%.

[0032] Embodiment 2:

[0033] A method for preparing a Chinese medicine composition extract for treating radiation-induced intestinal damage comprises the following steps:

[0034] (1) Cut the dried Pulsatilla striata, Phellodendron amurense, Coptis chinensis and Fraxinus chinensis into small pieces, weigh 50 g of Pulsatilla striata, 40 g of Phellodendron amurense, 30 g of Coptis chinensis and 40 g of Fraxinus chinensis, and soak them in 2 L of water for 1 h;

[0035] (2) pouring the soaked medicinal materials and the extract from step (1) into a multifunctional dynamic extraction tank and boiling for 1 hour, filtering the medicinal solution, then adding 1L of water and continuing to boil for 1 hour, filtering the medicinal solution and combining the two medicinal solutions to obtain a compound medicinal solution;

[0036] (3) The compound medicinal solution obtained in step (2) is concentrated using a multifunctional dynamic extraction concentrator to obtain an extract, which is then poured into an evaporating dish and placed in a -80°C refrigerator overnight. The next day, the evaporating dish is placed in a freeze dryer for freeze drying for 48 hours to obtain a Chinese medicine composition extract.

[0037] Embodiment 3:

[0038] A method for preparing a Chinese medicine composition extract for treating radiation-induced intestinal damage comprises the following steps:

[0039] (1) Cut the dried Pulsatilla striata, Phellodendron amurense, Coptis chinensis and Fraxinus chinensis into small pieces, weigh 300 g of Pulsatilla striata, 240 g of Phellodendron amurense, 180 g of Coptis chinensis and 240 g of Fraxinus chinensis, and soak them in 10 L of water for 1 h;

[0040] (2) pouring the soaked medicinal materials and the extract from step (1) into a multifunctional dynamic extraction tank and boiling for 1 hour, filtering the medicinal solution, then adding 8L of water and continuing to boil for 1 hour, filtering the medicinal solution and combining the two medicinal solutions to obtain a compound medicinal solution;

[0041] (3) The compound medicinal solution obtained in step (2) is concentrated using a multifunctional dynamic extraction concentrator to obtain an extract, which is then poured into an evaporating dish and placed in a -80°C refrigerator overnight. The next day, the evaporating dish is placed in a freeze dryer for freeze drying for 48 hours to obtain a Chinese medicine composition extract.

[0042] Test Example 1: Intestinal Pathological Damage Evaluation Experiment

[0043] The extract of the Chinese medicine composition prepared in Example 1 was administered intragastricly to perform an intestinal pathological injury (RII) evaluation experiment.

[0044] The experimental method is as follows: adult healthy male C57BL / 6J mice (7-8 weeks old, weighing 18-20g) were adaptively raised for one week. Before irradiation, each mouse received an abdominal injection of 0.2mL of sodium pentobarbital (mass concentration of 0.3%) to ensure its anesthesia during irradiation. Using a medical linear accelerator (CLINAC 23EX-SN297) X-ray 6MV mode, source skin distance 100cm, dose rate 400MU / min, mice were irradiated with 10Gy at one time to establish a mouse radiation enteropathy model. C57BL / 6J male mice were randomly divided into 6 groups, each containing 6 mice. They were normal control group, model group, low, medium and high dose groups of Chinese medicine composition, and the dosages were 0.65g / kg, 1.3g / kg and 2.6g / kg, respectively. After the modeling was completed, the low, medium and high dose groups were killed and the samples were collected after continuous gavage for 7 days. H&E staining was then performed. Chiu's score was used to evaluate the damage of intestinal tissue, and GraphPad Prism 8.4.0 software was used to analyze and calculate the statistical data.

[0045] The experimental results are shown in Table 1, where: ## P<0.01 compared with the control group; ** P<0.01 compared with the model group; * P<0.05 compared with the model group.

[0046] Table 1 Chinese herbal medicine extracts alleviate pathological damage in RII mouse model

[0047]

[0048]

[0049] The results of H&E staining showed that the Chinese medicine composition could significantly reduce intestinal mucosal atrophy and intestinal villus shedding, reduce the Chiu's score of intestinal tissue damage, and increase the length of intestinal villus and the number of crypts after treatment, indicating that the Chinese medicine composition can protect intestinal pathological damage and reduce intestinal bleeding.

[0050] Test Example 2: Evaluation of intestinal antioxidant and anti-inflammatory abilities

[0051] On the basis of Experimental Example 1, intestinal tissue samples were taken from each group of mice, and the ELISA kit, SOD kit and MDA kit were operated according to the operating instructions to detect the changes in the content of antioxidant enzymes (SOD), malondialdehyde (MDA), and inflammatory factors (IL-6, IL-10, IL-1β and TNF-α).

[0052] The experimental results are shown in Table 2 and Table 3, where: ## P<0.01 compared with the control group; **P<0.01 compared with the model group; * P<0.05 compared with the model group.

[0053] Table 2 The extracts of Chinese herbal medicine combination improve the intestinal antioxidant capacity of RII mouse model

[0054] Grouping SOD MDA Control group 133.13±2.44 8.01±0.81 Model Group <![CDATA[90.63±0.83 ## ]]> <![CDATA[18.62±1.58 ## ]]> Low dose group of Chinese medicine combination 100.32±2.50** 15.45±0.73** Chinese medicine composition medium dose group 108.96±1.13** 13.28±0.53** High dose group of Chinese medicine combination 116.01±2.82** 10.71±0.58**

[0055] Table 3 Chinese herbal medicine extract improves intestinal anti-inflammatory ability in RII mouse model

[0056] Grouping TNF-α IL-1β IL-6 IL-10 Control group 67.12±1.06 12.95±0.75 61.77±1.40 82.87±2.18 Model Group <![CDATA[89.27±0.48 ## ]]> <![CDATA[31.29±0.70 ## ]]> <![CDATA[95.94±4.17 ## ]]> <![CDATA[58.41±0.56 ## ]]> Low dose group of Chinese medicine combination 84.54±1.14* 26.32±1.20** 85.76±1.32** 62.38±1.14* Chinese medicine composition medium dose group 82.83±1.17** 23.96±1.91** 79.97±1.58** 65.81±1.09** High dose group of Chinese medicine combination 76.74±1.44** 17.94±1.86** 73.03±2.30** 71.55±1.08**

[0057] The results showed that compared with the control group, the activity of the intestinal antioxidant enzyme SOD in the model group was significantly reduced, the level of lipid peroxide MDA was significantly increased, the levels of proinflammatory factors TNF-α, IL-1β, and IL-6 were increased, and the level of anti-inflammatory factor IL-10 was reduced. The extract of the Chinese herbal composition dose-dependently inhibited the levels of proinflammatory factors TNF-α, IL-1β, and IL-6, promoted the secretion of anti-inflammatory factor IL-10, and alleviated intestinal inflammation. The extract of the Chinese herbal composition dose-dependently increased the activity of SOD and reduced the content of MDA, thereby improving the antioxidant capacity of the intestine. The results showed that the extract of the Chinese herbal composition can improve the antioxidant capacity of the intestinal tissue of irradiated mice and inhibit the intestinal inflammatory response caused by radiation.

[0058] Experimental Example 3: Apoptosis and Proliferation Evaluation Experiment of Intestinal Cells

[0059] On the basis of Experimental Example 1, intestinal tissue sections were taken from mice in each group, and cell apoptosis was detected by TUNEL method, and proliferation-related protein Ki67 was detected by immunofluorescence method to evaluate intestinal proliferation ability.

[0060] The experimental results are shown in Table 4. Among them, ## P < 0.01 compared with the control group; ** P<0.01 compared with the model group.

[0061] Table 4 Effects of extracts from Chinese herbal medicine combination on apoptosis and proliferation of intestinal cells in RII mouse model

[0062] Grouping Cell apoptosis rate (%) Number of proliferating cells in crypts Control group 1.11±0.54 32.33±1.96 Model Group <![CDATA[22.13±1.48 ## ]]> <![CDATA[3.66±1.50 ## ]]> Low dose group of Chinese medicine combination 13.01±1.40** 9.00±3.03** Chinese medicine composition medium dose group 5.90±0.98** 18.16±3.06** High dose group of Chinese medicine combination 3.06±0.78** 25.50±2.42**

[0063] The results showed that after radiation, intestinal cell apoptosis in the model group increased significantly, Ki67 protein expression decreased significantly, and cell proliferation ability decreased. After treatment with the extract of the Chinese herbal composition, the apoptosis of intestinal cells was reduced in a dose-dependent manner and the expression of Ki67 protein was promoted. The results showed that the extract of the Chinese herbal composition can effectively reduce the apoptosis of intestinal cells and promote the proliferation of intestinal cells, ensuring the balance between the intestinal barrier function and cell replacement in mice.

[0064] Test Example 4: Intestinal mucosal function evaluation experiment

[0065] On the basis of Experimental Example 1, intestinal tissue sections of mice in each group were taken, and AB-PAS staining was used to detect intestinal mucosal damage and count the number of intestinal goblet cells. AB-PAS staining technology can simultaneously detect neutral mucin and acidic mucin in tissue sections, and can dye goblet cells into dot-shaped blue-purple.

[0066] The experimental results are shown in Table 5. Among them, ## P < 0.01 compared with the control group; ** P<0.01 compared with the model group.

[0067] Table 5 Chinese herbal medicine extract promotes intestinal mucin secretion in RII mouse model

[0068] Grouping Intestinal goblet cell count Control group 95.66±5.50 Model Group <![CDATA[40.00±6.83 ## ]]> Low dose group of Chinese medicine combination 65.20±9.98** Chinese medicine composition medium dose group 72.60±8.90** High dose group of Chinese medicine combination 81.33±4.58**

[0069] The results showed that the number of intestinal mucosal goblet cells in the model group mice was significantly reduced, and the intestinal mucosal barrier function was impaired. After treatment with the Chinese medicine composition extract, the number of intestinal mucosal goblet cells in the mice increased significantly, and the low, medium and high dose groups of the Chinese medicine composition showed a dose-dependent increase in the number of intestinal goblet cells. The results showed that the Chinese medicine composition extract can effectively reduce the damage of intestinal mucosal goblet cells caused by radiation, promote the formation of intestinal mucus layer, reduce intestinal mucosal permeability, and thus improve the intestinal barrier function of mice.

[0070] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A Chinese medicine composition for treating radiation-induced intestinal damage, characterized in that: The invention comprises the following components in parts by weight: 5-30 parts of Pulsatillae, 4-24 parts of Fraxinus chinensis, 4-24 parts of Phellodendron amurense and 3-18 parts of Coptis chinensis.

2. The Chinese medicine composition for treating radiation-induced intestinal damage according to claim 1, characterized in that: The composition comprises the following components in parts by weight: 16.5 parts of Pulsatilla striata, 13.2 parts of Fraxinus chinensis, 13.2 parts of Phellodendron chinense and 6.6 parts of Coptis chinensis.

3. A method for preparing a Chinese medicine composition extract for treating radiation-induced intestinal damage, characterized in that: The following steps are involved: (1) Weigh the Chinese medicine composition according to claim 1 or 2 and soak it in water; (2) decocting the soaked medicinal materials and the soaking liquid in step (1) to obtain a compound medicinal liquid; (3) The compound medicinal solution obtained in step (2) is concentrated and dried to obtain the product.

4. The method for preparing the extract of the Chinese medicinal composition for treating radiation-induced intestinal injury according to claim 3, characterized in that: In the step (1), the mass ratio of the Chinese medicine composition to water is 1:5-15, and the soaking time is 0.5-2h.

5. The method for preparing the extract of the Chinese medicinal composition for treating radiation-induced intestinal damage according to claim 3, characterized in that: The decoction method in step (2) is: first decoct the medicinal materials and the infusion for 0.5 to 2 hours, filter the medicinal solution, then add water 3 to 8 times the weight of the medicinal materials and decoct again for 0.5 to 2 hours, filter and combine the medicinal solutions obtained from the two decoctions.

6. The method for preparing the extract of the Chinese medicinal composition for treating radiation-induced intestinal damage according to claim 3, characterized in that: The drying conditions in step (3) are: firstly treating the concentrated product at -90 to -70°C overnight, and then freeze-drying for 24 to 72 hours.

7. A Chinese medicine composition extract for treating radiation-induced intestinal damage, characterized in that: The method is prepared by any one of claims 3 to 6.

8. Use of the Chinese medicine composition according to claim 1 or 2 or the extract of the Chinese medicine composition according to claim 7 in the preparation of a medicament for treating radiation enteropathy.

9. The use according to claim 8, characterized in that: The radiation enteropathy includes acute radiation enteropathy, chronic radiation enteropathy, ulcerative colitis and intestinal obstruction.

10. A drug for treating radiation enteropathy, characterized in that: The active ingredient comprises the Chinese medicine composition according to claim 1 or 2 or the extract of the Chinese medicine composition according to claim 7.